Two students from the University of Cincinnati recently applied for a provisional patent on the design and prototype of a prescription-medicine pill bottle that would help people who are blind and visually impaired.

New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic.

At one University of Cincinnati laboratory, the phrase “battle of the sexes” is taking on new meaning, with implications for our understanding of evolution.

A research partnership represented by the University of Cincinnati, Cincinnati Children’s Hospital Medical Center and the Veterans Health Administration (VHA) National Center for Organization Development (NCOD) is examining factors predicting the turnover of senior executives in the federal workplace.

University of Cincinnati chemist Edward J. Merino is using metabolic "pollution" to target improved anticancer treatments.